Summary

Clarifies that certain controlled-substance crimes apply when committed on board covered vessels by explicitly tying each listed offense to being "on board a covered vessel." Requires the Coast Guard to update its overdose-medication policies so naloxone (and similar medications) are available across installations and operational environments, join a Department of Defense medication-tracking system via a memorandum of understanding, and brief Congress on implementation and recent substance-use trends. The bill sets specific deadlines (policy and MOUs within one year; congressional briefing within two years), requires privacy-law compliance for medication-tracking participation, and provides a narrow rule of construction about how availability on an installation is satisfied.

• The statute for controlled-substance offenses is revised to explicitly tie listed offenses to acts committed on board covered vessels.
• Prohibited acts on vessels are spelled out: manufacture/distribute, possess with intent to manufacture/distribute, or place a substance on board with such intent.
• The Coast Guard must update overdose-medication policy (including naloxone/fentanyl-specific measures) within one year.
• Naloxone or similar opioid-overdose medication must be available on all Coast Guard installations and in each operational environment.
• The Coast Guard must join a DoD opioid-overdose medication tracking system and finalize an access MOU within a one-year deadline tied to enactment or system establishment.
• The Commandant must brief Congress within two years on implementation, substance-use trends over five years, mitigation steps, MOU status, and naloxone usage.
• Privacy law compliance (the Privacy Act and HIPAA privacy rules) is required for participation in the tracking system.
• No new appropriations or explicit funding authority are specified in the bill text.
• A facility on an installation can satisfy availability requirements if it holds naloxone and provides 24/7 access arrangements.